Clinical Trial Update: SERI® Surgical Scaffold Postmarket Study of Soft Tissue Support in Ventral Hernia Repair [NA]

View source ↗

Summary

Postmarket study of SERI Surgical Scaffold in ventral hernia repair has been terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventral Hernia

Drugs mentioned

• SERI Surgical Scaffold

Snippet

Sponsor: Sofregen Medical, Inc. | Conditions: Ventral Hernia Repair | NA | Status: TERMINATED | Results posted: 2022-08-26